SHANNON KEISER: Open Payments
NPI 1306320031 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,367 in 130 payments from 17 companies in 2025. Trend: 2023 $2,310 · 2024 $2,352 · 2025 $2,367
Food & beverage: $2,267Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $448 |
| Regeneron Healthcare Solutions, Inc. | 12 | $379 |
| Janssen Biotech, Inc. | 20 | $303 |
| Galderma Laboratories, L.P. | 19 | $221 |
| PFIZER INC. | 10 | $190 |
| Lilly USA, LLC | 13 | $167 |
| Organon LLC | 4 | $159 |
| Novartis Pharmaceuticals Corporation | 13 | $157 |
| Incyte Corporation | 4 | $88 |
| GENZYME CORPORATION | 2 | $56 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, COSENTYX, RINVOQ, VTAMA, TALTZ.
Industry payments across IL — which companies pay providers there.
